On November 28, 2022 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) reported its participation in the following investor conferences taking place November 29 – December 1, 2022 (Press release, Lexicon Pharmaceuticals, NOV 28, 2022, http://www.lexpharma.com/media-center/news/830-lexicon-pharmaceuticals-to-participate-in-the-34th-annual-piper-sandler-healthcare-conference-and-the-5th-annual-evercore-isi-healthconx-conference [SID1234624505]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

34th Annual Piper Sandler Healthcare Conference
5th Annual Evercore ISI HealthCONx Conference
Lonnel Coats, Lexicon’s chief executive officer, Jeffrey L. Wade, Lexicon’s president and chief financial officer, and Craig Granowitz, M.D., Ph.D., Lexicon’s senior vice president and chief medical officer, will participate in moderated discussions at the Piper Sandler conference on Tuesday, November 29th, at 11:00 am ET and at the Evercore ISI conference on Thursday, December 1st at 8:00 am ET.

A simultaneous webcast of both discussions will be available in the "Events" section of the Lexicon website at www.lexpharma.com/events, and a recording of the webcast will be available for two weeks following the original on-demand date.